IP Library Granted Patent US 7,732,595
Granted Patent B2
US 7,732,595 · App. 11/701,699 · Granted Jun 8, 2010

Process for preparing an A

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,732,595
App. No.
11/701,699
Granted
Jun 8, 2010
Kind
B2
Abstract

Disclosed is a synthesis suitable for large scale manufacture of an A 2A -adenosine receptor agonist, and also relates to polymorphs of that compound, and to methods of isolating a specific polymorph. The A 2A -adenosine receptor agonist has the following formula: This compound is prepared by reacting the ethyl ester with methylamine in a sealed pressure reactor.

Claims (34)

1. A method for the large scale preparation of (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide:

comprising:

reacting a compound of the formula (3)

with methylamine wherein the compound of formula (3) is reacted with an aqueous solution of methylamine at an initial temperature of about 0-5° C. followed by warming to about 50-70° C. in a sealed pressure reactor.

2. The method of claim 1 , further comprising wherein the (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl)pyrazol-4-yl)-N-methylcarboxamide end product is isolated as the pure monohydrate by

(a) dissolving the product in a solvent,

(b) adding purified water,

(c) filtering the slurry thus formed,

(d) washing the contents of the filter with water followed by ethanol, and

(e) drying the solid that remains under vacuum at a temperature that does not exceed 40° C.

3. The method of claim 2 , wherein the solvent of step (a) is dimethylsulfoxide.

4. A method of preparing a compound of the formula (3):

comprising:

reacting a compound of the formula (2)

with ethyl 2-formyl-3-oxopropionate wherein about 1.1 molar equivalent of ethyl 2-formyl-3-oxopropionate is reacted with the compound of formula (2) in a solvent.

5. The method of claim 4 , wherein the solvent is ethanol.

6. The method of claim 5 , wherein the reaction is conducted at a temperature of about 80° C.

7. A method of synthesizing (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide

comprising by contacting a compound of the formula (4):

with an aqueous solution of methylamine at an initial temperature of about 0-5° C. followed by warming to about 50-70° C. in a sealed pressure reactor.

8. The method of claim 7 , further comprising wherein the (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide end product is isolated as the pure monohydrate by

(a) dissolving the product of claim 7 in a solvent,

(b) adding purified water,

(c) filtering the slurry thus formed,

(d) washing the contents of the filter with water followed by ethanol, and

(e) drying the solid that remains under vacuum at a temperature that does not exceed 40° C.

9. The method of claim 8 , wherein the solvent of step (a) is dimethylsulfoxide.

10. A method of synthesizing a compound of the formula (4):

comprising

contacting a compound of the formula (2):

with an excess of ethyl 2-formyl-3-oxopropionate wherein about a 2-10 fold molar excess of ethyl 2-formyl-3-oxopropionate is reacted with the compound of the formula (2) in a solvent.

11. The method of claim 10 , wherein the solvent is ethanol.

12. The method of claim 11 wherein the reaction is conducted at a temperature of about 80° C.

13. The method of claim 10 , wherein about a 5-10 fold molar excess of ethyl 2-formyl-3-oxopropionate is reacted with the compound of the formula (2).

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2013
From: LEMONS, TRAVIS; SEEMAYER, ROBERT
To: GILEAD SCIENCES, INC.
Reel/Frame 029716/0839 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2011
From: GILEAD PALO ALTO, INC.
To: GILEAD SCIENCES, INC.
Reel/Frame 026424/0925 →
MERGER Recorded Jan 14, 2010
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 023790/0759 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2010
From: TPG-AXON ROYALTY TRUST
To: TPG-AXON LEX SUB-TRUST
Reel/Frame 023731/0916 →
MERGER Recorded Oct 6, 2009
From: GILEAD PALO ALTO, INC.
To: TPG-AXON ROYALTY TRUST
Reel/Frame 023330/0648 →
SECURITY AGREEMENT Recorded Apr 16, 2008
From: CV THERAPEUTICS, INC.
To: TPG-AXON ROYALTY TRUST
Reel/Frame 020808/0823 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2007
From: ZABLOCKI, JEFF; ELZEIN, ELFATIH
To: CV THERAPEUTICS, INC.
Reel/Frame 019646/0780 →